NEW YORK — U.S. health officials are pleading for more use of COVID-19 antibody therapies from Eli Lilly and Co. and Regeneron Pharmaceuticals Inc. that have been plagued by logistical
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has made a $30 million limited partner investment in a newly-formed venture fund. The company says Unseen Capital Health Fund LP seeks to identify, fun